187 related articles for article (PubMed ID: 36740804)
1. Roles of Nuclear Receptors in Esophageal Cancer.
Deng L; Liu J; Chen WD; Wang YD
Curr Pharm Biotechnol; 2023; 24(12):1489-1503. PubMed ID: 36740804
[TBL] [Abstract][Full Text] [Related]
2. Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer.
Jayaprakash S; Hegde M; Girisa S; Alqahtani MS; Abbas M; Lee EHC; Yap KC; Sethi G; Kumar AP; Kunnumakkara AB
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142861
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease.
Ning L; Lou X; Zhang F; Xu G
Mediators Inflamm; 2019; 2019():2624941. PubMed ID: 30804707
[TBL] [Abstract][Full Text] [Related]
4. Chemokines and their receptors as biomarkers in esophageal cancer.
Goto M; Liu M
Esophagus; 2020 Apr; 17(2):113-121. PubMed ID: 31773415
[TBL] [Abstract][Full Text] [Related]
5. Nuclear receptors: Lipid and hormone sensors with essential roles in the control of cancer development.
Font-Díaz J; Jiménez-Panizo A; Caelles C; Vivanco MD; Pérez P; Aranda A; Estébanez-Perpiñá E; Castrillo A; Ricote M; Valledor AF
Semin Cancer Biol; 2021 Aug; 73():58-75. PubMed ID: 33309851
[TBL] [Abstract][Full Text] [Related]
6. The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease.
Yang Z; Danzeng A; Liu Q; Zeng C; Xu L; Mo J; Pingcuo C; Wang X; Wang C; Zhang B; Zhang B
Int J Biol Sci; 2024; 20(1):113-126. PubMed ID: 38164174
[TBL] [Abstract][Full Text] [Related]
7. The emerging roles of orphan nuclear receptors in prostate cancer.
Wu D; Cheung A; Wang Y; Yu S; Chan FL
Biochim Biophys Acta; 2016 Aug; 1866(1):23-36. PubMed ID: 27264242
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Receptors as Potential Therapeutic Targets for Myeloid Leukemia.
Pan P; Chen X
Cells; 2020 Aug; 9(9):. PubMed ID: 32824945
[TBL] [Abstract][Full Text] [Related]
10. Macrophage nuclear receptors: Emerging key players in infectious diseases.
Leopold Wager CM; Arnett E; Schlesinger LS
PLoS Pathog; 2019 Mar; 15(3):e1007585. PubMed ID: 30897154
[TBL] [Abstract][Full Text] [Related]
11. Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease.
Fuchs CD; Traussnigg SA; Trauner M
Semin Liver Dis; 2016 Feb; 36(1):69-86. PubMed ID: 26870934
[TBL] [Abstract][Full Text] [Related]
12. The Role of Nuclear Receptors in Prostate Cancer.
Shiota M; Fujimoto N; Kashiwagi E; Eto M
Cells; 2019 Jun; 8(6):. PubMed ID: 31212954
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptors in the kidney during health and disease.
Libby AE; Jones B; Lopez-Santiago I; Rowland E; Levi M
Mol Aspects Med; 2021 Apr; 78():100935. PubMed ID: 33272705
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Expression of Fibroblast Growth Factor Receptor 3 IIIc Promotes Human Esophageal Carcinoma Cell Proliferation.
Ueno N; Shimizu A; Kanai M; Iwaya Y; Ueda S; Nakayama J; Seo MK
J Histochem Cytochem; 2016 Jan; 64(1):7-17. PubMed ID: 26487184
[TBL] [Abstract][Full Text] [Related]
15. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
17. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
Mulholland DJ; Dedhar S; Coetzee GA; Nelson CC
Endocr Rev; 2005 Dec; 26(7):898-915. PubMed ID: 16126938
[TBL] [Abstract][Full Text] [Related]
18. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
19. P2Y
Zaparte A; Cappellari AR; Brandão CA; de Souza JB; Borges TJ; Kist LW; Bogo MR; Zerbini LF; Ribeiro Pinto LF; Glaser T; Gonçalves MCB; Naaldijk Y; Ulrich H; Morrone FB
Eur J Pharmacol; 2021 Jan; 891():173687. PubMed ID: 33130276
[TBL] [Abstract][Full Text] [Related]
20. Bile acids and derivatives, their nuclear receptors FXR, PXR and ligands: role in health and disease and their therapeutic potential.
Zimber A; Gespach C
Anticancer Agents Med Chem; 2008 Jun; 8(5):540-63. PubMed ID: 18537536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
